Forsta Ap Fonden Regeneron Pharmaceuticals, Inc. Transaction History

Forsta Ap Fonden

$13.7 Billion
Q4 2024

A detailed history of Forsta Ap Fonden transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Forsta Ap Fonden holds 22,100 shares of REGN stock, worth $15.6 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

22,100

Previous 24,500 9.8%

Holding current value

$15.6 Million

Previous $25.8 Million 38.88%

% of portfolio

0.11%

Previous 0.2%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	SELL	$701.85 - $1046.91 $1.68 Million - $2.51 Million	-2,400 Reduced 9.8%	22,100 $15.7 Million
Q3 2024 Oct 24, 2024	BUY	$1024.09 - $1201.76 $2.25 Million - $2.64 Million	2,200 Added 9.87%	24,500 $25.8 Million
Q2 2024 Aug 08, 2024	SELL	$883.2 - $1071.19 $529,920 - $642,714	-600 Reduced 2.62%	22,300 $23.4 Million
Q1 2024 May 07, 2024	BUY	$902.69 - $993.35 $2.62 Million - $2.88 Million	2,900 Added 14.5%	22,900 $22 Million
Q4 2023 Feb 06, 2024	SELL	$775.18 - $881.7 $387,590 - $440,850	-500 Reduced 2.44%	20,000 $17.6 Million
Q3 2023 Oct 25, 2023	BUY	$692.45 - $844.37 $138,490 - $168,874	200 Added 0.99%	20,500 $16.9 Million
Q2 2023 Aug 03, 2023	SELL	$700.03 - $830.35 $140,006 - $166,070	-200 Reduced 0.98%	20,300 $14.6 Million
Q1 2023 Apr 21, 2023	SELL	$680.49 - $826.97 $3.2 Million - $3.89 Million	-4,700 Reduced 18.65%	20,500 $16.8 Million
Q4 2022 Feb 02, 2023	SELL	$705.89 - $766.39 $1.84 Million - $1.99 Million	-2,600 Reduced 9.35%	25,200 $18.2 Million
Q3 2022 Oct 17, 2022	SELL	$573.97 - $724.32 $229,588 - $289,728	-400 Reduced 1.42%	27,800 $19.2 Million
Q2 2022 Aug 11, 2022	SELL	$548.35 - $738.84 $274,175 - $369,420	-500 Reduced 1.74%	28,200 $16.7 Million
Q1 2022 May 09, 2022	SELL	$595.12 - $698.43 $1.31 Million - $1.54 Million	-2,200 Reduced 7.12%	28,700 $20 Million
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $543,480 - $670,970	1,000 Added 3.34%	30,900 $19.5 Million
Q3 2021 Nov 10, 2021	BUY	$574.03 - $680.96 $1.03 Million - $1.23 Million	1,800 Added 6.41%	29,900 $18.1 Million
Q2 2021 Aug 12, 2021	BUY	$472.8 - $558.54 $1.09 Million - $1.28 Million	2,300 Added 8.91%	28,100 $15.7 Million
Q1 2021 May 11, 2021	BUY	$446.73 - $548.2 $2.05 Million - $2.52 Million	4,600 Added 21.7%	25,800 $12.2 Million
Q4 2020 Feb 09, 2021	BUY	$478.3 - $607.98 $573,960 - $729,576	1,200 Added 6.0%	21,200 $10.2 Million
Q3 2020 Feb 19, 2021	BUY	$544.75 - $658.21 $10.9 Million - $13.2 Million	20,000 New	20,000 $11.2 Million
Q3 2020 Oct 22, 2020	SELL	$544.75 - $658.21 $7.41 Million - $8.95 Million	-13,600 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$493.32 - $643.92 $2.17 Million - $2.83 Million	4,400 Added 47.83%	13,600 $8.48 Million
Q1 2020 May 04, 2020	BUY	$336.18 - $494.43 $3.09 Million - $4.55 Million	9,200 New	9,200 $4.49 Million

Others Institutions Holding REGN

# of Institutions

1,489

Shares Held

85.7M

Call Options Held

1.53M

Put Options Held

1.44M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.

Account